New Cellgorithm™ data presented at ISSCR symposium indicates faster, scalable cell programming and add to Syntax Bio’s ...

Syntax, a New York-based fintech company pioneering economic data intelligence and next-generation index technologies, today announced a deep technology integration with Schwab Advisor Services™, ...

Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...

The integration links index creation, index calculation, model management, trading and tax management support for RIAs. iRebal users can access Syntax Direct through single sign-o ...

CHICAGO-- (BUSINESS WIRE)-- Syntax Bio will present new research on its Cellgorithm™ cell-programming platform at the ...

Syntax Bio, a privately held synthetic biology company focused on cell therapies, on Sunday said it expanded its Series A financing round to $14.4 million, bringing total funding raised to more than ...

If there’s one thing you can be sure of, it’s that English Syntax can definitely get interesting. Syntax is the branch of linguistics that deals with sentences and their structures. In case you’re ...

"We are committed to delivering excellence to our customers so they can in turn drive the success of their global businesses," said Christian Primeau, Global CEO of Syntax. "However, none of this ...